FDA grants 2 doctors special permit to use leronlimab vs COVID-19

enablePagination: false
maxItemsPerPage: 10
maxPaginationLinks: 10


Metro Manila (CNN Philippines, April 19) — The country's Food and Drug Administration has allowed two physicians to prescribe experimental drug leronimab to their COVID-19 patients, its chief said on Monday.

With the granting of the compassionate special permit, FDA Director General Eric Domingo said the two unnamed doctors are only allowed to give the medicine to one patient each.

A CSP holder has to take full responsibility for the use and dispensing of the said drug. The permit is valid only for one year.

Leronimab is undergoing clinical trials for the treatment of cancer and Human Immunodeficiency Virus or HIV. Now it is also being investigated for use in the treatment of COVID-19.

Former President Joseph Estrada was given leronlimab to treat his COVID-19, his son former Jinggoy Estrada revealed in an interview with ANC on Monday. He has survived his bout with COVID-19, but remains in the hospital for a bacterial lung infection.

CNN Philippines correspondent Carolyn Bonquin contributed to this report.